Skip to main contentSkip to navigation
SeniorCRE Logo
Clinical Workflow 03 of 17

How does the eMAR enforce medication safety and DEA-compliant controlled substance handling?

Roadmap — not yet shipped

The platform does not yet ship a dedicated module for this workflow. The "How the platform runs it" description below reflects designed-and-planned behavior, not currently shipping code. Outcome figures are modeled targets.

Primary decision maker: DONAlso: COOLast reviewed:

Expected outcome

Transcription and PRN follow-up evidence

Modeled from workflow design and industry benchmarks. No customer communities measured yet — figures are targets, not validated results. See Industry Findings for methodology.

The problem

Medication errors are the number one clinical liability in senior housing & care. Most happen during transcription, administration, or because a PRN follow-up was forgotten. Paper MARs cannot prevent any of these, and most electronic MARs only digitize the paper rather than enforce the workflow.

How the platform runs it

Proposed eMAR workflow — roadmap, not built or validated in community operation. Governed order information and medication-administration reconciliation would require completed integrations, implementation, clinical workflow validation, and operator authorization. Clinicians would verify medication rights and decide on administration; order interfaces, interaction or allergy alerts, witnessed waste documentation, and PRN prompts are intended architecture, not currently operational safety controls. The selected configuration must preserve one authoritative medication record.

Illustrative proposed workflow

Illustrative example on synthetic data. Names, figures, and events are not from any operator community.

Illustrative design walkthrough — eMAR is roadmap, not built. The proposed medication pass would present governed order information for clinician review, subject to completed integrations, implementation, clinical workflow validation, and operator authorization. A clinician would verify resident identity and medication rights; no operational barcode check, order interface, administration alert, dose block, or automated clinical execution is claimed. Proposed controlled-substance reconciliation, witnessed documentation, and PRN follow-up prompts would require clinical acceptance. Exactly one medication record would remain authoritative for the chosen deployment configuration.

What the outcome looks like

Evidence focus: transcription variance, PRN follow-up documentation, and controlled-substance reconciliation are governed for review against the operator’s own baseline. No measured operator outcome is claimed here.

What goes wrong without it

On a paper MAR or a basic eMAR, the same shift compounds risk. Transcription from the fax to the MAR introduces one error in roughly every hundred orders. The hold for low blood pressure is a decision the med tech has to remember to make. The narcotic count is reconciled at shift change against a paper log that may have been signed late or signed wrong; discrepancies are noticed days later when the DEA-style audit pulls. PRN follow-up is whatever the nurse remembers to write at the end of the shift, which is why pain reassessment compliance hovers at 60% and surveyors keep finding it.

Where this connects in the platform

Every clinical workflow runs on the same record. These are the feature pages, head-to-head comparisons, and pillar articles that go deeper on the surfaces this workflow touches.

Clinical and quality references

Clinical workflows on this page run against the CMS RAI/MDS manual, the Quality Measure technical specifications, and the recognized clinical practice guidelines published by AGS, IDSA, and the Wound, Ostomy and Continence Nurses Society.

Stay up to date

The Senior Housing Journal, in your inbox

Perspectives on operator-governed operating information, capital and operating developments across senior housing & care, and platform updates from SeniorCRE.

By subscribing, you agree to receive the Senior Housing Journal newsletter. Unsubscribe at any time. See our Privacy Policy.